Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Gold/Mining/Energy : Inflazyme Pharmaceuticals (T.IZP) -- Ignore unavailable to you. Want to Upgrade?

To: Bob Schommer who wrote (1202)	3/19/1999 10:54:00 AM
From: Rob	Respond to of 1501

I spoke to Michael Ligget yesterday (CFO) about the status of the toxicity studies. He said the results would be in by the end of March or beginning of April at which time the company would issue an informational release. I didn't sense any indication in our discussion of catastrophic or seriously untoward side effects being discovered. Hopefully the pathology data will concur and disclose no significant effect on major organ systems. We should have some answers fairly soon. I also inquired about the preferred shares and agree with Harold's interpretation. Rob